Form 4: Director Alessandro Riva Sells BeOne Medicines Shares

Director Alessandro Riva sold 212 American Depositary Shares of BeOne Medicines Ltd. to satisfy mandatory tax withholding obligations.

Summary

• Director Alessandro Riva disposed of 212 American Depositary Shares (ADS) of BeOne Medicines Ltd. (ONC).
• The transaction occurred on May 22, 2026, at a price of $309.5142 per share.
• Following the transaction, the director holds 0 ADS and 54,184 Ordinary Shares.
• Each ADS represents 13 Ordinary Shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was purely administrative to satisfy tax obligations rather than a discretionary divestment.

Positives

• The sale was a non-discretionary transaction triggered by mandatory tax withholding requirements related to the vesting of restricted share units.

Negatives

• Reduction in direct equity holdings by a member of the Board of Directors.

Risks

• Vesting of restricted share units is contingent upon continued service as a director.
• Vesting may be impacted by resignation or cessation of service on the board.

Future Outlook

No specific forward-looking guidance regarding company performance was provided in this filing.

Management Comments

• The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement.

Industry Context

StockSavvy.ai notes that mandatory tax withholding sales are standard corporate governance practices for directors receiving equity-based compensation and generally do not signal a change in management sentiment regarding the company's outlook.

Comparison to Industry Standards

• The transaction follows standard SEC reporting requirements for equity compensation vesting.
• The use of mandatory tax withholding is a common practice among publicly traded biotechnology and pharmaceutical firms.

Stakeholder Impact

• Minimal impact on shareholders as the transaction was a routine tax-related sell-to-cover event.

Next Steps

• Continued service of the director to ensure full vesting of remaining restricted share units.

Key Dates

Keywords

BeOne Medicines, ONC, Insider Trading, Form 4, Alessandro Riva, Equity Vesting